Diagnosis of ntm mycobacterium for md exams full details

Reading Document
Medical Text Search

non-tuberculous mycobacteria NTM diagnosis criteria clinical features

Medical Text Search

NTM mycobacterium pulmonary disease microbiological diagnostic workup culture bronchoscopy

GradeResponse
GradeResponse
Excellent — I have strong guideline-based content. Let me now compile the full, comprehensive answer for MD exams.

Non-Tuberculous Mycobacteria (NTM) — Diagnosis: Full MD Exam Guide


1. Introduction & Classification

Non-tuberculous mycobacteria (NTM) are mycobacterial species other than M. tuberculosis complex and M. leprae. Also called:
  • Atypical mycobacteria
  • Environmental mycobacteria
  • MOTT (Mycobacteria Other Than Tuberculosis)

Runyon Classification (Classic Exam Table)

GroupNameGrowthPigmentKey Species
IPhotochromogensSlowIn lightM. kansasii, M. marinum
IIScotochromogensSlowIn darkM. scrofulaceum, M. gordonae
IIINonchromogensSlowNoneM. avium complex (MAC), M. ulcerans, M. xenopi
IVRapid growersFast (<7 days)VariableM. fortuitum, M. chelonae, M. abscessus
Exam tip: MAC (Group III) is the most common NTM causing pulmonary disease in immunocompetent adults.

2. Epidemiology & Risk Factors

Host Risk Factors

Pulmonary NTM:
  • Structural lung disease: bronchiectasis, COPD, prior TB, pneumoconiosis, CF
  • Lady Windermere syndrome: slender, elderly women with scoliosis/pectus excavatum
  • Immunosuppression (HIV/AIDS — CD4 <50 for disseminated MAC)
  • Use of inhaled corticosteroids
Disseminated NTM:
  • HIV with CD4 <50 cells/µL (MAC most common)
  • Primary immunodeficiencies (IFN-γ/IL-12 pathway defects)
  • Anti-IFN-γ autoantibodies (Southeast Asian patients)

3. Clinical Presentations

A. Pulmonary Disease (Most Common Form)

Two main radiologic patterns:
FeatureFibrocavitary FormNodular Bronchiectatic Form
DemographicsOlder males, smokersOlder women (Lady Windermere)
Chest X-rayApical cavitiesMiddle lobe/lingular nodules
HRCTThick-walled cavitiesTree-in-bud, bronchiectasis, nodules
SpeciesM. kansasii, MACMAC
CourseMore aggressiveIndolent
Symptoms: Chronic cough, hemoptysis, fatigue, weight loss, night sweats — indistinguishable from pulmonary TB

B. Lymphadenitis

  • Most common NTM disease in children
  • Cervical > submandibular nodes (unilateral, non-tender)
  • Species: MAC > M. scrofulaceum > M. kansasii
  • Violaceous skin, may spontaneously drain (scrofula-like, but NTM in immunocompetent child)
  • Exam key: NTM lymphadenitis in a child — not MTB; treat with surgical excision

C. Skin and Soft Tissue / Bone

  • Buruli ulcer: M. ulcerans — painless necrotic ulcer, Africa; toxin mycolactone
  • Fish tank granuloma: M. marinum — nodular lesion on hand/elbow after aquarium exposure
  • Rapidly growing mycobacteria (RGM): M. abscessus, M. fortuitum — post-surgical/injection abscesses

D. Disseminated MAC (HIV)

  • CD4 <50 cells/µL
  • Fever, night sweats, weight loss, hepatosplenomegaly
  • Very high LDH and alkaline phosphatase
  • Pancytopenia (bone marrow infiltration)
  • Diagnosis: blood culture (lysis-centrifugation) or bone marrow biopsy

4. Diagnosis — The Core Exam Topic

ATS/IDSA Diagnostic Criteria for NTM Pulmonary Disease (2020 Guidelines)

Treatment of Nontuberculous Mycobacterial Pulmonary Disease, ATS/ERS/ESCMID/IDSA, p. 2
Both clinical AND microbiologic criteria must be met:

✅ CLINICAL Criteria (BOTH required):

  1. Pulmonary symptoms (cough, hemoptysis, dyspnea) AND
  2. Radiographic findings: nodular or cavitary opacities on CXR, OR HRCT showing multifocal bronchiectasis with multiple small nodules
  3. Appropriate exclusion of other diagnoses (TB, fungi, malignancy)

✅ MICROBIOLOGIC Criteria (ONE of the following):

OptionRequirement
Sputum cultures≥2 positive sputum cultures for the same NTM species
Bronchoscopy≥1 positive bronchial wash/lavage culture
BiopsyTransbronchial/lung biopsy with granulomatous inflammation or AFB + ≥1 positive NTM culture from sputum/lavage
Critical exam point (ATS 2020, p. 2): A single positive sputum culture is NOT diagnostic — clinically significant MAC pulmonary disease is unlikely with 1 positive culture but up to 98% likely with ≥2 positive cultures of the same species.

Diagnostic Workup — Step by Step

Step 1: Clinical suspicion
        ↓
Step 2: Chest X-ray + HRCT chest
        ↓
Step 3: Sputum × 3 (AFB smear + Mycobacterial culture)
        ↓ (if sputum non-diagnostic)
Step 4: Bronchoscopy → BAL / bronchial wash for AFB culture
        ↓ (if still needed)
Step 5: CT-guided lung biopsy / transbronchial biopsy
        ↓
Step 6: Species identification (nucleic acid probes, HPLC, 16S rRNA gene sequencing)
        ↓
Step 7: Drug susceptibility testing (DST)

Key Laboratory Investigations

TestDetails
AFB smearRapid but low sensitivity; cannot distinguish NTM from MTB
Mycobacterial cultureGold standard; Lowenstein-Jensen (L-J) or MGIT liquid media; 2–6 weeks for slow growers, <7 days for rapid growers
Species identificationDNA probes (AccuProbe), 16S rRNA sequencing, MALDI-TOF, HPLC
Drug Susceptibility Testing (DST)Essential for treatment planning
HRCT chestBronchiectasis + tree-in-bud nodules (nodular-bronchiectatic); cavities (fibrocavitary)
CBC, LFT, ALPElevated ALP/LDH → disseminated MAC
HIV testMandatory in disseminated NTM
Blood cultureLysis-centrifugation for disseminated MAC (HIV)
Bone marrow biopsyDisseminated MAC — granulomas with AFB
Interferon-gamma Release Assay (IGRA)NEGATIVE in NTM (does not cross-react with MAC/NTM); positive only for MTB ✓
Tuberculin Skin Test (TST/Mantoux)May be weakly positive (cross-reactivity with M. kansasii, M. marinum) but weaker than MTB
Exam trap: IGRA (QuantiFERON-TB Gold) is negative in NTM — this helps differentiate NTM from MTB. TST can show weak positivity with some NTM species.

HRCT Findings — High-Yield

PatternDescriptionAssociated Form
Tree-in-bud nodulesCentrilobular nodules with branchingNodular-bronchiectatic
Cylindrical bronchiectasisMiddle lobe & lingula predominantlyNodular-bronchiectatic (Lady Windermere)
CavitationThin or thick-walled apical cavitiesFibrocavitary
ConsolidationSegmental/lobarHypersensitivity-like (hot tub lung)
Ground glass opacitiesDiffuse in hypersensitivity pneumonitis variantHot tub lung (M. avium)

5. Specific NTM Species — Diagnosis Pearls

SpeciesKey Clinical PearlDiagnosis Clue
MAC (M. avium-intracellulare)Most common NTM; pulmonary + disseminated in AIDS≥2 sputum cultures; blood culture in HIV
M. kansasiiResembles TB clinically and radiologically; apical cavitiesPositive AccuProbe; responds to rifampicin
M. abscessusMost drug-resistant NTM; CF patientsRGM <7 days; macrolide susceptibility testing critical
M. fortuitumPost-surgical/injection abscessesRGM; skin/soft tissue
M. marinumAquarium/fish tank exposure; fish tank granulomaHistory + skin biopsy + culture at 30°C (not 37°C!)
M. ulceransBuruli ulcer; painless necrotic ulcerPCR + culture; Africa/Australia
M. scrofulaceumCervical lymphadenitis in childrenSurgical excision diagnostic + curative
M. xenopiPulmonary; immunocompromised; UK commonSlow grower at 42°C
M. haemophilumSkin/joint in immunocompromisedRequires iron-supplemented media + 30°C
Exam tip for M. marinum: Culture must be done at 30°C, not 37°C — it will not grow at body temperature. Exam tip for M. haemophilum: Requires hemin-supplemented media — lab must be alerted.

6. Differentiating NTM from MTB — Exam Table

FeatureNTMMTB
TransmissionEnvironmental (soil, water) — NOT person-to-personPerson-to-person (droplet)
ContagiousNoYes
Contact tracingNot requiredRequired
IsolationNot requiredRequired
IGRA / QuantiFERONNegativePositive
TSTWeak/negative (except M. kansasii)Strongly positive
Culture timeWeeks (varies by species)3–6 weeks
Drug sensitivityResistant to many anti-TB drugsStandard RHEZ regimen
Niacin testNegativePositive (MTB)
Nitrate reductionVariesPositive (MTB)
Growth on PNB (p-nitrobenzoic acid)Grows (NTM)Inhibited (MTB)

7. Special Scenarios

Hot Tub Lung (M. avium)

  • Hypersensitivity pneumonitis from MAC aerosolized in hot tubs
  • Dyspnea, cough, fever after hot tub exposure
  • HRCT: diffuse ground glass + nodules
  • Diagnosis: BAL + culture + clinical history
  • Treatment: Avoidance (± steroids) — antituberculars not always needed

Lady Windermere Syndrome

  • Elderly, slender women; right middle lobe/lingula bronchiectasis
  • MAC most common
  • Chronic productive cough; no underlying lung disease
  • Caused by deliberate cough suppression → impaired mucociliary clearance

NTM in Cystic Fibrosis (ATS/IDSA Guidelines, p. 8)

  • M. abscessus most important — can prevent lung transplantation
  • Screening with annual sputum AFB cultures recommended
  • Diagnosis: same ATS/IDSA criteria apply
  • Treatment challenging — multidrug regimens, surgical debridement

Disseminated MAC in HIV

  • CD4 <50 → start MAC prophylaxis (azithromycin weekly)
  • Diagnosis: blood cultures (lysis-centrifugation) — most sensitive
  • Features: fever, wasting, hepatosplenomegaly, markedly elevated ALP

8. Key Exam Points — Quick Recall

#High-Yield Point
1≥2 positive sputum cultures required for NTM-PD diagnosis (same species)
2Single positive sputum = NOT diagnostic
3IGRA negative in NTM (key differentiator from TB)
4NTM is NOT transmitted person-to-person — no isolation/contact tracing
5M. marinum culture at 30°C; M. haemophilum needs hemin media
6Niacin test positive → MTB; NTM = negative
7PNB (p-nitrobenzoic acid): NTM grows; MTB is inhibited
8Disseminated MAC in HIV: CD4 <50; diagnose with blood cultures
9M. abscessus = most drug-resistant NTM; common in CF
10Lady Windermere = elderly woman + MAC + RML/lingula bronchiectasis
11Children with cervical lymphadenitis → NTM (MAC/M. scrofulaceum); treat with excision
12Buruli ulcer = M. ulcerans; Fish tank granuloma = M. marinum
13Making a diagnosis of NTM-PD does NOT automatically mandate treatment — individualize

9. Summary Diagnostic Algorithm

Suspected NTM disease
         │
    ┌────▼────┐
    │ Clinical │ Symptoms + CXR/HRCT (nodules, bronchiectasis, cavities)
    └────┬────┘
         │
    ┌────▼────────────┐
    │ Sputum AFB ×3   │ Culture on Lowenstein-Jensen / MGIT
    └────┬────────────┘
         │
   ┌─────▼──────┐
   │ ≥2 positive │ → Identify species (AccuProbe / 16S rRNA)
   │ same species│ → DST → Diagnose NTM-PD ✓
   └─────┬───────┘
         │ If non-diagnostic
    ┌────▼──────────────┐
    │ Bronchoscopy BAL  │ ≥1 positive culture → Diagnose NTM-PD ✓
    └────┬──────────────┘
         │ Still inconclusive
    ┌────▼──────────────┐
    │ Lung biopsy       │ Granulomas/AFB + ≥1 culture → Diagnose ✓
    └───────────────────┘

Sources: ATS/ERS/ESCMID/IDSA Treatment of Nontuberculous Mycobacterial Pulmonary Disease (2020), p. 2; Management of NTM in Individuals with Cystic Fibrosis (ATS/IDSA), p. 8; supplemented with Harrison's Principles of Internal Medicine and standard microbiology references.
This is a shared conversation. Sign in to Orris to start your own chat.